- |||||||||| Cytorex EBV (baltaleucel-T) / Baylor College of Medicine, Houston Methodist Hospital, Texas Children's Hospital, Athenex
Trial primary completion date: Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma (clinicaltrials.gov) - Jan 27, 2016
P2, N=30, Recruiting,
Not yet recruiting --> Recruiting Trial primary completion date: Dec 2016 --> Jun 2017
- |||||||||| Cytorex EBV (baltaleucel-T) / Baylor College of Medicine, Houston Methodist Hospital, Texas Children's Hospital, Athenex
Enrollment open: Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma (clinicaltrials.gov) - Sep 5, 2014
P2, N=30, Recruiting,
Initiation date: Oct 2015 --> Aug 2016 | Trial primary completion date: Nov 2018 --> Sep 2019 Not yet recruiting --> Recruiting
- |||||||||| Cytorex EBV (baltaleucel-T) / Baylor College of Medicine, Houston Methodist Hospital, Texas Children's Hospital, Athenex
Trial primary completion date: Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma (clinicaltrials.gov) - Jun 13, 2014
P2, N=30, Not yet recruiting,
Not yet recruiting --> Recruiting Trial primary completion date: Sep 2016 --> Dec 2016
- |||||||||| Cytorex EBV (baltaleucel-T) / Baylor College of Medicine, Houston Methodist Hospital, Texas Children's Hospital, Athenex
Trial initiation date: Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma (clinicaltrials.gov) - May 13, 2014
P2, N=30, Active, not recruiting,
Trial primary completion date: Sep 2016 --> Dec 2016 Initiation date: Jan 2014 --> Jun 2014
- |||||||||| Cytorex EBV (baltaleucel-T) / Baylor College of Medicine, Houston Methodist Hospital, Texas Children's Hospital, Athenex
Enrollment closed: Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma (clinicaltrials.gov) - May 13, 2014
P2, N=30, Active, not recruiting,
Initiation date: Jan 2014 --> Jun 2014 Not yet recruiting --> Active, not recruiting
|
